Climate change in Washington related emissions are the dominant source of GHG emissions and have increased from 61.2 MMT CO-equivalent (CO-e) in 1990 (excluding residual fuel for transportation) to 74.6 MMT CO-e in 2004, while their share has increased from 79% of total emissions to 85% over the past fourteen years. Carbon dioxide is the dominant GHG followed by methane, nitrous oxide, perfluorocarbon and sulfur hexafluoride. Non-energy industrial global greenhouse gas emissions have lowered from 14% to 9%, mainly due to reduced emissions from aluminum production. This has been the result of two key elements: process changes that reduced CO and PFC emissions per
Nitrous oxide gas-ether inhaler, to initiate the anaesthesia with nitrous oxide, before the administration of a more powerful anaesthetic. Colton's popularization of nitrous oxide led to its adoption by a number of less than reputable quacksalvers, who touted it as a cure for consumption, scrofula, catarrh, and other diseases of the blood, throat, and lungs. Nitrous oxide treatment was administered and licensed as a patent medicine by the likes of C. L. Blood and Jerome Harris in Boston and Charles E. Barney of Chicago. Reviewing various methods of producing nitrous oxde is published. Nitrous oxide is prepared on an industrial scale by